This idiot thinks it knows better than the FDA and all the MDs that have tested and approved VB-111. LOL @theidiot
absolutely. 100% is a low number. This stock will rock once trial 3 is announced, and they add new indications.
People who are too stupid to understand the results should ask the FDA why this company is on Fast Track and approved to go to Phase 3
ement will present a company overview at the following conferences in May:
Deutsche Bank 40th Annual Health Care Conference in Boston, MA on Wednesday, May 6, 2015, at 2:50 p.m. ET. A live webcast will be available by visiting the investor relations section of VBL's website.
Oppenheimer 16th Annual Israeli Conference, in Tel-Aviv, Israel on Sunday, May 10, 2015, at 1:10 p.m. IST (6:10 am ET).
IATI Biomed 2015 Conference in Tel Aviv, Israel on Wednesday, May 13, 2015, at 2:20 p.m. IST (7:20 a.m. ET).
ASCO May 29 to June 2, 2015